Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Equity Ratio (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Equity Ratio for 5 consecutive years, with 0.49 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio rose 73.15% year-over-year to 0.49, compared with a TTM value of 0.49 through Sep 2025, up 73.15%, and an annual FY2024 reading of 0.18, up 307.11% over the prior year.
  • Equity Ratio was 0.49 for Q3 2025 at Lucid Diagnostics, up from 0.2 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.93 in Q4 2021 and bottomed at 7.32 in Q3 2021.
  • Average Equity Ratio over 5 years is 0.04, with a median of 0.37 recorded in 2024.
  • The sharpest move saw Equity Ratio surged 307.11% in 2024, then crashed 144.18% in 2025.
  • Year by year, Equity Ratio stood at 0.93 in 2021, then decreased by 23.59% to 0.71 in 2022, then crashed by 111.95% to 0.08 in 2023, then surged by 307.11% to 0.18 in 2024, then skyrocketed by 176.69% to 0.49 in 2025.
  • Business Quant data shows Equity Ratio for LUCD at 0.49 in Q3 2025, 0.2 in Q2 2025, and 0.16 in Q1 2025.